Hepatic arterial infusion after liver resection [7]

New England Journal of Medicine

Volumn 352, Issue 7, 2005, Pages 734-735

  Kemeny, Nancy E ^a   Gonen, Mithat ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; COLORECTAL CANCER; DISEASE COURSE; HEPATIC ARTERY; HUMAN; LETTER; LIVER RESECTION; MONOTHERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DEXAMETHASONE; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE;

EID: 13744255337     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200502173520723     Document Type: Letter

References (2)

1. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-48.
2. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-21.